Nocopi’s Q3 Cash Position Improved 12% from June 2021 to $2.1M Despite Drop in Product Revenue Related to Customer Supply Chain Challenges, Names New Independent Director
Nocopi Technologies (OTC Pink: NNUP) reported Q3’21 results, showing a 59% drop in revenue to $312,500 due to decreased specialty ink shipments, offset by a 45% increase in license and royalty income to $222,500. Gross profit fell 51% to $209,200, but gross margin improved to 67%. Operating expenses reduced by 12%, and net income decreased to $1,100. Cash from operations declined to $228,200, though year-to-date cash increased by 4% to $802,600. Supply chain issues impacted production orders, but management remains optimistic about future growth.
- License and royalty revenue increased 45% to $222,500.
- Gross margin improved from 56% to 67% despite lower product sales.
- Operating expenses reduced by 12%, reflecting managed costs.
- Cash position increased to $2.1M in Q3'21, a rise from $1.9M in Q2'21.
- Q3’21 revenue decreased 59% to $312,500 due to lower specialty ink orders.
- Gross profit declined 51% to $209,200, impacted by significant decreases in product sales.
- Net income fell to $1,100 from $163,100 in Q3’20.
- Consumer demand remains strong, but supply chain disruptions continue to affect production.
KING OF PRUSSIA, Pa., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Nocopi Technologies, Inc. (OTC Pink: NNUP), a developer of specialty reactive inks used in entertainment, toy and educational products as well as in document and product authentication technologies to combat fraud, today announced results for its third quarter and nine months ended September 30, 2021 (Q3’21 & 9M’21). Nocopi’s SEC filings are available here.
Q3’21 Results
Q3’21 revenue declined
Gross profit declined
Q3’21 operating expenses declined
Reflecting a decrease in gross profit, Nocopi’s net income decreased to
Nocopi’s Q3’21 results were significantly impacted by a decrease in orders for its specialty ink technologies as major licensees deferred production activity in response to substantial challenges, delays and higher costs they are experiencing in both printing and producing products in Asia and then shipping to the U.S. and other global markets. Consumer demand for the products marketed by Nocopi’s licensees continues to be strong and growing.
Highlights
- Nocopi reported breakeven operations in Q3’21 despite a
59% decrease in revenue to$312,500 , due to lower specialty ink sales offset in part by a45% increase in revenues from licenses, royalties and fees. Revenues for 9M’21 were$1,437,800 versus 9M’20 revenues of$1,902,400. - Nocopi appointed independent director Joe Raymond to its Board of Directors, increasing the board to four members, three of whom are independent.
- Q3’21 cash rose
$0.2M to$2.1M vs.$1.9M in Q2'21 and$1.4M at year-end 2020.
Nocopi Chairman and CEO Michael Feinstein commented, “Persistent global supply chain disruptions, shipping delays and higher costs being faced by our licensees have resulted in a drop in their production of new products, translating into a decline in our specialty ink orders during the third quarter. While we are confident that these issues will be resolved, and believe our business will return to historical demand patterns and growth, it is too early to try to predict the scope or timing of such a rebound.
Importantly, over the past few years we have placed our company on a very solid financial footing, growing working capital to
Importantly, our hybrid business model – which combines product sales with royalty payments – has enabled Nocopi to grow our cash position by
Nocopi has recently named Joe Raymond as our third independent Director. Joe brings business and capital markets experience to guide and support our corporate strategy and growth objectives. Joe is a talented investment analyst specializing in small-cap and microcap securities and shares our belief in Nocopi’s long term outlook.”
About Nocopi Technologies (www.nocopi.com)
Nocopi develops and markets specialty reactive inks for unique, mess-free applications in the entertainment, toy and educational product markets. Nocopi also develops and markets document and product authentication technologies designed to combat fraudulent document reproduction, product counterfeiting and/or unauthorized product diversion. Nocopi derives revenue from technology licensing agreements as well as from the sale of its proprietary inks and other products to licensees and/or their licensed printers. Nocopi’s products and systems include trade secrets as well as patented technologies.
Safe Harbor for Forward-Looking Statements
This release may contain projections and other "forward-looking statements" relating to Nocopi’s business, that are often identified by the use of "believes," "expects" or similar expressions. Forward-looking statements involve a number of estimates, assumptions, risks and uncertainties that may cause actual results to differ materially from those anticipated. Forward-looking statements may address uncertainties regarding customer preferences or demand for products incorporating Nocopi technology that underlie the company’s revenue expectations, the company’s ability to develop new products and new product applications, the financial condition of customers and the timeliness of their payments, the impact of fluctuations in currencies, global trade and shipping markets, etc. Actual results could differ from those projected due to numerous factors and uncertainties, and Nocopi can give no assurance that such statements will prove to be correct nor that Nocopi’s actual results of operations, financial condition and performance will not differ materially from those reflected or implied by its forward-looking statements. Investors should refer to the risk factors outlined in Nocopi’s Form 10-K, 10-Q and other SEC reports available at www.sec.gov/edgar. Forward-looking statements are made as of the date of this news release; Nocopi assumes no obligation to update these statements.
Twitter – Investors: @NNUP_IR
Investor & Media Contacts
Chris Eddy or David Collins
Catalyst IR
212-924-9800
nnup@catalyst-ir.com
Nocopi Technologies, Inc.
Statements of Comprehensive Income
(unaudited)
Three Months ended September 30, | Nine Months ended September 30, | ||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||
Revenues | |||||||||||||||
Licenses, royalties and fees | $ | 222,500 | $ | 153,300 | $ | 552,900 | $ | 425,000 | |||||||
Product and other sales | 90,000 | 601,500 | 884,900 | 1,477,400 | |||||||||||
312,500 | 754,800 | 1,437,800 | 1,902,400 | ||||||||||||
Cost of revenues | |||||||||||||||
Licenses, royalties and fees | 28,300 | 61,900 | 124,900 | 170,200 | |||||||||||
Product and other sales | 75,000 | 267,400 | 432,500 | 716,200 | |||||||||||
103,300 | 329,300 | 557,400 | 886,400 | ||||||||||||
Gross profit | 209,200 | 425,500 | 880,400 | 1,016,000 | |||||||||||
Operating expenses | |||||||||||||||
Research and development | 44,000 | 40,700 | 134,300 | 123,700 | |||||||||||
Sales and marketing | 56,600 | 90,900 | 214,000 | 260,900 | |||||||||||
General and administrative | 122,300 | 123,800 | 385,500 | 383,500 | |||||||||||
222,900 | 255,400 | 733,800 | 768,100 | ||||||||||||
Net income (loss) from operations | (13,700 | ) | 170,100 | 146,600 | 247,900 | ||||||||||
Other income (expenses) | |||||||||||||||
Interest income | 5,100 | 4,200 | 15,200 | 12,300 | |||||||||||
Interest expense and bank charges | (500 | ) | (1,300 | ) | (1,700 | ) | (5,900 | ) | |||||||
4,600 | 2,900 | 13,500 | 6,400 | ||||||||||||
Net income (loss) before income taxes | (9,100 | ) | 173,000 | 160,100 | 254,300 | ||||||||||
Income taxes | (10,200 | ) | 9,900 | 1,700 | (32,200 | ) | |||||||||
Net income | $ | 1,100 | $ | 163,100 | $ | 158,400 | $ | 286,500 | |||||||
Basic and diluted net income per common share | $ | .00 | $ | .00 | $ | .00 | $ | .00 | |||||||
Weighted average common shares outstanding | |||||||||||||||
Basic | 67,495,055 | 66,768,023 | 67,416,519 | 62,952,473 | |||||||||||
Diluted | 67,495,055 | 66,893,250 | 67,416,519 | 63,069,652 | |||||||||||
Nocopi Technologies, Inc.
Balance Sheets
September 30, | December 31, | ||||||
2021 | 2020 | ||||||
(unaudited) | |||||||
Assets | |||||||
Current assets | |||||||
Cash | $ | 2,136,600 | $ | 1,362,800 | |||
Accounts receivable less | 668,400 | 1,280,800 | |||||
Inventory | 480,400 | 324,800 | |||||
Prepaid and other | 130,700 | 97,800 | |||||
Total current assets | 3,416,100 | 3,066,200 | |||||
Fixed assets | |||||||
Leasehold improvements | 58,400 | 27,800 | |||||
Furniture, fixtures and equipment | 164,100 | 163,700 | |||||
222,500 | 191,500 | ||||||
Less: accumulated depreciation and amortization | 125,300 | 104,300 | |||||
97,200 | 87,200 | ||||||
Other assets | |||||||
Long-term receivables | 278,100 | 559,500 | |||||
Operating lease right of use - building | 127,200 | 160,300 | |||||
405,300 | 719,800 | ||||||
Total assets | $ | 3,918,600 | $ | 3,873,200 | |||
Liabilities and Stockholders' Equity | |||||||
Current liabilities | |||||||
Accounts payable | $ | 14,200 | $ | 5,700 | |||
Accrued expenses | 143,400 | 178,600 | |||||
Income taxes | – | 36,300 | |||||
Operating lease liability, current | 46,700 | 44,500 | |||||
Total current liabilities | 204,300 | 265,100 | |||||
Other liabilities | |||||||
Accrued expenses, non-current | 19,500 | 39,200 | |||||
Operating lease liability, non-current | 80,500 | 115,800 | |||||
100,000 | 155,000 | ||||||
Stockholders' equity | |||||||
Common stock, | |||||||
Authorized – 75,000,000 shares | |||||||
Issued and outstanding | |||||||
2021 – 67,495,055; 2020 – 67,353,690 shares | 675,000 | 673,500 | |||||
Paid-in capital | 12,577,100 | 12,575,800 | |||||
Accumulated deficit | (9,637,800 | ) | (9,796,200 | ) | |||
Total stockholders' equity | 3614,300 | 3,453,100 | |||||
Total liabilities and stockholders' equity | $ | 3,918,600 | $ | 3,873,200 |
FAQ
What were Nocopi Technologies' Q3 2021 revenue figures?
How did Nocopi's license and royalty revenue perform in Q3 2021?
What is the current cash position of Nocopi Technologies as of Q3 2021?
What impact did supply chain issues have on Nocopi Technologies' Q3 2021 results?